Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancerAnita K. Mehta, Jennifer L. Guerriero, Matthew J. Berberich et al.|Nature Cancer|2020Cited by 271
STING agonism enhances anti-tumor immune responses and therapeutic efficacy of PARP inhibition in BRCA-associated breast cancerConstantia Pantelidou, Geoffrey I. Shapiro|npj Breast Cancer|2022Cited by 33
860 Targeting immunosuppressive macrophages overcomes PARP-inhibitor resistance in BRCA1-associated triple-negative breast cancerAnita K. Mehta, Jennifer L. Guerriero, Emily Cheney et al.|Unknown|2020Cited by 25
The E1B19K-deleted oncolytic adenovirus mutant AdΔ19K sensitizes pancreatic cancer cells to drug-induced DNA-damage by down-regulating Claspin and Mre11Constantia Pantelidou, Gunnel Halldén|Oncotarget|2016Cited by 22
STING agonism enhances anti-tumor immune responses and therapeutic efficacy of PARP inhibition in <i>BRCA</i> -associated breast cancerConstantia Pantelidou, Geoffrey I. Shapiro|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 5